Howard L Kaufman Selected Research

Howard L Kaufman Research Topics

Disease

127	Neoplasms (Cancer) 05/2024 - 01/2002
78	Melanoma (Melanoma, Malignant) 04/2024 - 08/2002
21	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 01/2005
11	Merkel Cell Carcinoma 01/2022 - 10/2016
8	Vaccinia 01/2023 - 04/2004
7	Infections 01/2020 - 12/2004
6	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016 - 02/2002
6	Prostatic Neoplasms (Prostate Cancer) 02/2016 - 04/2002
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 07/2021
5	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2002
5	Colorectal Neoplasms (Colorectal Cancer) 09/2011 - 08/2008
4	Skin Neoplasms (Skin Cancer) 01/2023 - 02/2017
4	Disease Progression 01/2019 - 08/2008
4	Carcinogenesis 10/2016 - 01/2006
3	Chills 01/2022 - 09/2015
3	Fever (Fevers) 01/2022 - 05/2014
3	Carcinoma (Carcinomatosis) 01/2021 - 12/2004
3	Brain Neoplasms (Brain Tumor) 01/2019 - 08/2015
3	Herpes Simplex 12/2018 - 07/2010
3	Kidney Neoplasms (Kidney Cancer) 03/2014 - 11/2010
2	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 01/2019
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2022 - 10/2016
2	Human Influenza (Influenza) 01/2020 - 10/2016
2	Fatigue 10/2018 - 09/2015
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 05/2014
2	Experimental Melanoma 01/2015 - 02/2009
2	Adenocarcinoma 05/2011 - 10/2010
1	Newcastle Disease 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Neuralgia (Stump Neuralgia) 01/2022
1	Osteomyelitis 07/2021
1	Burns 07/2021
1	Ulcer 07/2021
1	Varicose Ulcer (Ulcer, Venous) 07/2021
1	Wounds and Injuries (Trauma) 07/2021
1	Cicatrix (Scar) 07/2021
1	COVID-19 01/2020

Drug/Important Bio-Agent (IBA)

33	Interleukin-2 (IL2)IBA 04/2024 - 03/2002
28	VaccinesIBA 04/2024 - 02/2002
28	AntigensIBA 11/2018 - 03/2002
25	talimogene laherparepvecIBA 04/2024 - 01/2014
20	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2024 - 12/2009
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2009
12	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2016
9	CytokinesIBA 12/2023 - 05/2004
9	IpilimumabIBA 01/2022 - 06/2013
8	AntibodiesIBA 05/2024 - 05/2007
8	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2002
8	avelumabIBA 01/2019 - 10/2016
6	Monoclonal AntibodiesIBA 01/2017 - 05/2004
5	pembrolizumabIBA 06/2023 - 01/2016
5	Neoplasm Antigens (Tumor Antigens)IBA 10/2019 - 06/2006
5	ChemokinesIBA 01/2019 - 01/2002
5	Cancer VaccinesIBA 04/2017 - 03/2002
5	TroVax (5T4 cancer vaccine)IBA 01/2012 - 10/2010
4	Interleukin-12 (IL 12)IBA 12/2023 - 03/2002
4	LigandsIBA 11/2018 - 06/2013
4	Carcinoembryonic AntigenIBA 05/2014 - 06/2002
4	DNA (Deoxyribonucleic Acid)IBA 02/2013 - 12/2005
3	trametinibIBA 01/2022 - 12/2018
3	Glycoproteins (Glycoprotein)IBA 10/2019 - 04/2002
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 06/2013
3	RNA (Ribonucleic Acid)IBA 01/2018 - 06/2015
3	EpitopesIBA 10/2010 - 04/2002
2	NivolumabIBA 01/2022 - 12/2021
2	dabrafenibIBA 01/2022 - 12/2021
2	VemurafenibIBA 12/2021 - 06/2013
2	InterferonsIBA 01/2019 - 11/2010
2	B7-H1 AntigenIBA 01/2018 - 01/2017
2	TIC10 compoundIBA 08/2017 - 11/2016
2	Programmed Cell Death 1 ReceptorIBA 10/2016 - 01/2016
2	CTLA-4 AntigenIBA 01/2016 - 01/2015
2	B7 AntigensIBA 05/2014 - 02/2006
2	Sunitinib (Sutent)FDA Link 06/2011 - 11/2010
2	Gemcitabine FDA Link 05/2011 - 02/2003
2	Fluorouracil (Carac)FDA LinkGeneric 05/2011 - 08/2008
2	Therapeutic UsesIBA 10/2010 - 06/2006
2	CD58 Antigens (LFA-3)IBA 06/2006 - 02/2006
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2006 - 02/2006
2	Peptides (Polypeptides)IBA 12/2005 - 05/2004
2	Prostate-Specific Antigen (Semenogelase)IBA 06/2004 - 04/2002
1	Antineoplastic Agents (Antineoplastics)IBA 12/2023
1	cemiplimabIBA 10/2022
1	EnzymesIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 10/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020

Therapy/Procedure

84	Immunotherapy 01/2023 - 02/2002
66	Therapeutics 01/2023 - 06/2002
12	Drug Therapy (Chemotherapy) 01/2019 - 02/2002
4	Injections 12/2023 - 09/2015
4	Radiotherapy 01/2023 - 10/2005
4	Oncolytic Virotherapy 05/2021 - 01/2013
2	Intralesional Injections 01/2019 - 05/2014
2	Intravenous Infusions 01/2018 - 01/2018
2	Aftercare (After-Treatment) 01/2018 - 01/2016
2	Castration 02/2016 - 01/2011
2	Combination Drug Therapy (Combination Chemotherapy) 06/2013 - 08/2008
1	Neoadjuvant Therapy 10/2022
1	Intramuscular Injections 01/2020